- Publication date
- 11 June 2014
- Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR)
WG on Nanosilver
SCENIHR members: Philippe Hartemann, Peter Hoet, Ana Proykova
SCHER member: Teresa Fernandes
External experts: Anders Baun, Wim De Jong, Juliane Filser, Arne Hensten, Carsten Kneuer, Jean-Yves Maillard, Hannu Norppa, Martin Scheringer, Susan Wijnhoven
Acknowledgement: Martin Hoppe and Carsten Schlich who kindly provided up-to-date literature lists for silver nanoparticles in soils. Natalie von Goetz who provided recent literature on silver in food contact materials. Lutz Mädler and Jorg Thöming who contributed with important insights for Life-cycle assessment (LCA)
Contact:SANCO-C2-SCENIHRec [dot] europa [dot] eu (SANCO-C2-SCENIHR[at]ec[dot]europa[dot]eu)
On request from: European Commission
Adopted on: 11 June 2014
Content of the opinion:
The opinion assesses whether the use of nanosilver, in particular in medical care and in consumer products, could result in additional risks compared to more traditional uses of silver and whether the use of nanosilver to control bacterial growth could result in resistance of micro-organisms. The SCENIHR concluded that the widespread and increasing use of silver containing products implicates that both consumers and the environment are exposed to new sources of silver. Human exposure is direct (food, hand-to-mouth contact, skin) and may be lifelong; while in the environment silver nanoparticles may be a particularly effective delivery system for silver to organisms in soil, water and sediment and may act as sources of ionic silver over extended periods of time. Therefore, additional effects caused by widespread and long term use of silver nanoparticles cannot be ruled out. Regarding the hazard associated with the dissemination of the resistance mechanism following the use of silver nanoparticles, no studies are available at this moment, representing a serious gap of knowledge. Since other nanoparticles have been shown to substantially increase the horizontal gene transfer between bacteria – which is extremely relevant for developing resistance – the potential of silver nanoparticles to induce similar effects should be given particular attention. More data are needed to better understand bacterial response to ionic silver and silver nanoparticles exposure. Since the mechanisms resulting in silver nanoparticles resistance are not well understood, it is not possible to estimate at this time whether or not resistance of microorganisms will increase and spread in view of a more widespread use of silver nanoparticles in products.
Nanosilver, risk assessment, antibacterial activity, medical care products, antimicrobial resistance
Opinion to be cited as:
SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks), Nanosilver: safety, health and environmental effects and role in antimicrobial resistance, 11 June 2014.